EMEA-001828-PIP01-15-M01

Key facts

Active substance
Recombinant human alpha-galactosidase A (PRX 102)
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/0286/2018
PIP number
EMEA-001828-PIP01-15-M01
Pharmaceutical form(s)
Solution for infusion
Condition(s) / indication(s)
Treatment of Fabry disease
Route(s) of administration
Intravenous use
Contact for public enquiries
Protalix Ltd

Tel. +972 545676383
E-mail: einata@protalix.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating